Stock
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales...
Hi, what are you looking for?
Investing.com – Johnson & Johnson (NYSE:JNJ) posted fourth-quarter adjusted earnings and sales that topped analysts’ estimates, as the pharmaceutical firm was boosted by demand...
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales...
Investing.com — Textron Inc. reported fourth-quarter 2024 earnings that fell short of analyst expectations, sending shares down 1.5% in early trading. The aerospace and...
Investing.com — Fifteen provinces in China have revised their GDP growth targets for 2025, with most setting their aim between 5% and 6%. Qinghai...
Investing.com — President Donald Trump has granted a full pardon to Ross Ulbricht, the founder of the dark-web marketplace, Silk Road. This action took...
(Reuters) – The new Trump administration’s policies may affect inflation in the United States but are unlikely to have much impact on price pressures...
Investing.com — Yannis Stournaras, a member of the European Central Bank’s Governing Council, has advised that the bank should continue to gradually reduce interest...
Investing.com — Analysts from Nordea Bank Abp (OTC:NRDBY) predict that the central banks of Sweden and Norway will end their current easing cycle within...